Roivant Sciences Ltd. Common Shares (NASDAQ: ROIV) last traded at $36.30, down 1.47% on the session. The quote above updates while this page is open; the figures below are drawn from Roivant Sciences Ltd. Common Shares’s own filings and are restated only when a new one is published.
Roivant Sciences Ltd. Common Shares trades on NASDAQ under the ticker ROIV. Its market capitalisation is $26.22 billion.
Valuation measures for Roivant Sciences Ltd. Common Shares, derived from the latest quote and its most recent SEC filing.
| Market cap | $26.22B |
|---|---|
| Enterprise value | $25.36B |
| Price / sales | 3481.19 |
| Price / book | 6.20 |
| Beta | 1.06 |
Trailing-twelve-month figures tagged in Roivant Sciences Ltd. Common Shares's XBRL filings with the SEC.
| Revenue (TTM) | $7.53M |
|---|---|
| Net income (TTM) | -$266.25M |
| EPS (TTM) | -$0.470 |
| Operating margin | -7914.75% |
| Return on equity | -6.29% |
| Cash | $1.25B |
Range and volume for ROIV over the past 52 weeks.
| 52-week high | $37.97 |
|---|---|
| 52-week low | $11.60 |
| Volume | 5.77M |
| Average volume | 5.66M |
| Previous close | $36.84 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.